Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypoxia × alovudine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 10 Breast Neoplasms 8 Neoplasms 4 Head and Neck Neoplasms 4 Central Nervous System Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 2 Prostatic Neoplasms 2 Oligodendroglioma 2 Melanoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Glioma 2 Glioblastoma 2 Ependymoma 2 Carcinoma, Renal Cell 2 Astrocytoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Lymphoma 1 Lymphatic Metastasis 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 5 pimonidazole 4 fluoroazomycin arabinoside 4 TH 302 4 Radiotherapy 3 Propofol 3 Injections 3 pomalidomide 1 gadobutrol 1 fluoromisonidazole 1 fludarabine 1 alovudine 1 Tirapazamine 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Temozolomide 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Pancreaticoduodenectomy 1 Oxygen 1 Nitroglycerin 1 Nimorazole 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Letrozole 1 Ketamine 1 Ipilimumab 1 Hydroxychloroquine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00159978 2015-05-07

Validation of 18F-MISO-PET and 18F-FLT-PET

Radboud University Medical Center

Hypoxia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡